Genomic Testing Training for Physicians

The course is a 1-day intensive. You may also opt-in to the comprehensive livestream version of this course for remote participation.

No, the course is structured to start from fundamental concepts, ensuring all participants can follow and gain valuable insights regardless of prior experience in genetics or genomics.

Yes, you will leave the course with practical skills, but integrating testing into your practice may require additional equipment or partnerships with testing laboratories for processing samples and generating reports.

Genomic testing is a growing field that enhances diagnostic capabilities and patient care. By earning this certification, you gain an edge in offering advanced, personalized medical services that meet modern patient expectations for precision medicine.

Yes, participants have access to continued learning resources, periodic updates, and expert consultations to ensure successful implementation of genomic testing services in their practice.

The course is designed for doctors, nurses, medical practitioners, and professionals interested in precision medicine and personalized healthcare. It is particularly relevant for those seeking to address chronic diseases, hereditary conditions, and medication response optimization in their patient populations.

Pharmacogenomic testing identifies patients who are poor metabolizers, normal metabolizers, or ultra-rapid metabolizers of specific medications — information that prevents adverse drug reactions, reduces trial-and-error prescribing, and improves treatment outcomes from the first prescription. Studies show pharmacogenomic-guided prescribing reduces adverse events by 30% and improves medication response rates by 70%. The course covers clinical implementation across major prescribing categories.

Coverage is expanding rapidly. Major insurers including Medicare now cover pharmacogenomic testing when ordered with appropriate clinical indications — particularly for pain management, psychiatric, and cardiovascular medications. The course covers CPT coding, clinical documentation requirements, and insurance authorization strategies that maximize reimbursement. For non-covered tests, cash-pay pricing is available in the $200–$400 range, well within patient willingness to pay for personalized medicine.

Genomic consultations command $250–$750+ per comprehensive interpretation session. Pharmacogenomic testing panels may be billed to insurance or offered at cash-pay rates. Beyond direct genomic service revenue, pharmacogenomic-guided prescribing improves treatment outcomes, enhances patient satisfaction, and creates practice differentiation that attracts patients seeking the highest standard of personalized medical care.

While physicians have the legal authority to perform many procedures, hands-on training under expert supervision dramatically accelerates the learning curve, reduces complication risk, and provides the clinical confidence needed to deliver exceptional patient outcomes from day one. Empire's structured curriculum, live patient practice, and CME accreditation also satisfy credentialing and malpractice insurance requirements that self-study alone cannot fulfill.

Adding procedural services creates new revenue streams that can significantly increase your practice income — aesthetic services alone can add $200K-$500K+ in annual revenue. Beyond finances, offering in-demand procedures improves patient retention, attracts new patient demographics, and positions your practice competitively in a market where patients increasingly expect comprehensive service offerings from their healthcare providers.

Yes. All Empire Medical Training courses for physicians are accredited through the Accreditation Council for Continuing Medical Education (ACCME) and provide AMA PRA Category 1 Credit™. These credits satisfy continuing medical education requirements for state license renewal and specialty board Maintenance of Certification (MOC) programs.